Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bausch + Lomb Corporation ( (BLCO) ) has shared an update.
Bausch + Lomb Corporation announced it will release its third-quarter 2025 financial results on October 29, 2025, followed by a conference call and webcast to discuss the results and provide a business update. Additionally, the company will hold an investor day on November 13, 2025, to highlight its product pipeline and potential innovations, signaling a focus on future growth and industry leadership.
The most recent analyst rating on (BLCO) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.
Spark’s Take on BLCO Stock
According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.
Bausch + Lomb Corporation’s overall stock score is primarily impacted by its mixed financial performance and challenging valuation. While there are positive aspects such as revenue growth and increased guidance, persistent profitability issues and weak cash flow generation weigh heavily. Technical analysis suggests a neutral to slightly bearish trend, and the earnings call sentiment is balanced, reflecting both achievements and challenges.
To see Spark’s full report on BLCO stock, click here.
More about Bausch + Lomb Corporation
Bausch + Lomb Corporation is a leading global eye health company focused on helping people improve their vision to enhance their quality of life. The company offers a wide range of products, including contact lenses, prescription products, over-the-counter options, and surgical devices, with a strong commitment to innovation and improving the standard of care in eye health.
Average Trading Volume: 752,474
Technical Sentiment Signal: Hold
Current Market Cap: $5.13B
For an in-depth examination of BLCO stock, go to TipRanks’ Overview page.